Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group

eJHaem ◽

10.1002/jha2.359 ◽

2022 ◽

Author(s):

Francesca Fazio ◽

Luca Franceschini ◽

Valeria Tomarchio ◽

Angela Rago ◽

Maria Grazia Garzia ◽

...

Keyword(s):

Multiple Myeloma ◽

Refractory Multiple Myeloma

Download Full-text

Continuous low-dose dexamethasone in relapsed or refractory multiple myeloma

British Journal of Haematology ◽

10.1046/j.1365-2141.2000.02372.x ◽

2000 ◽

Vol 111 (1) ◽

pp. 381-381 ◽

Cited By ~ 6

Author(s):

C. W. Tiplady ◽

G. P. Summerfield

Keyword(s):

Multiple Myeloma ◽

Low Dose ◽

Refractory Multiple Myeloma

Download Full-text

Drug combination shows benefit in relapsed/refractory multiple myeloma

PsycEXTRA Dataset ◽

10.1037/e458862008-004 ◽

2007 ◽

Keyword(s):

Multiple Myeloma ◽

Drug Combination ◽

Refractory Multiple Myeloma

Download Full-text

Decision letter for "A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma"

10.1002/hon.2820/v2/decision1 ◽

2020 ◽

Keyword(s):

Multiple Myeloma ◽

Real World ◽

Safety Analysis ◽

Efficacy And Safety ◽

Refractory Multiple Myeloma

Download Full-text

Unstable Plasma Thalidomide Concentration in Patients with Refractory Multiple Myeloma

Laboratory Hematology ◽

10.1532/lh96.04025 ◽

2004 ◽

Vol 10 (3) ◽

pp. 132-136 ◽

Cited By ~ 2

Author(s):

TOMOKO KODAMA ◽

RYUYA HORIUCHI ◽

NORIFUMI TSUKAMOTO ◽

YOSHIHISA NOJIMA ◽

HIROKAZU MURAKAMI

Keyword(s):

Multiple Myeloma ◽

Refractory Multiple Myeloma ◽

Unstable Plasma

Download Full-text

Blinatumomab Induced Response of Multiply Refractory Multiple Myeloma in the Context of Secondary Pre-B Cell Acute Lymphoblastic Leukemia

Annals of Hematology & Oncology ◽

10.26420/annhematoloncol.2017.1174 ◽

2017 ◽

Vol 4 (10) ◽

Cited By ~ 4

Author(s):

Keith W. Pratz

Keyword(s):

Multiple Myeloma ◽

Acute Lymphoblastic Leukemia ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Induced Response ◽

Refractory Multiple Myeloma ◽

Cell Acute Lymphoblastic Leukemia

Download Full-text

Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Case Medical Research ◽

10.31525/ct1-nct03836053 ◽

2000 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Refractory Multiple Myeloma

Download Full-text

Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma

Case Medical Research ◽

10.31525/ct1-nct03856112 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Refractory Multiple Myeloma

Download Full-text

BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma

Case Medical Research ◽

10.31525/ct1-nct03943472 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

T Cells ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

Refractory Multiple Myeloma

Download Full-text

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Case Medical Research ◽

10.31525/ct1-nct04017130 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Refractory Multiple Myeloma

Download Full-text

A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma

Case Medical Research ◽

10.31525/ct1-nct04036461 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Antibody Drug Conjugate ◽

Refractory Multiple Myeloma ◽

Drug Conjugate ◽

Antibody Drug

Download Full-text